NSE: SYNGENE

Syngene International: Navigating the Biologics Headwind in a Shifting CRO Landscape

By StreetVantage Intelligence // June 14, 2026

₹₹458.55

NEUTRAL

DISCLAIMER: Educational intelligence only. StreetVantage is NOT SEBI registered. Trading involve risk of loss.